Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Norepinephrine and dopamine systems" refers collectively to two major monoamine neurotransmitter pathways in the brain. Norepinephrine (also called noradrenaline) is produced primarily in the locus coeruleus of the brainstem and acts as both a neurotransmitter in the central nervous system and a hormone in the periphery. Dopamine is synthesized mainly by neurons in areas such as the substantia nigra and ventral tegmental area. Both are catecholamines derived from tyrosine via shared biosynthetic pathways; dopamine serves as a precursor for norepinephrine synthesis[4][7]. These neuromodulators play crucial roles in regulating arousal, attention, motivation, reward learning, movement coordination, stress response ("fight-or-flight"), mood regulation, vigilance, memory processes, sleep-wake cycles, blood pressure regulation—and are implicated in numerous neuropsychiatric conditions including depression (targeted by drugs like bupropion), ADHD, schizophrenia (via prefrontal cortex modulation), bipolar disorder as well as neurodegenerative diseases such as Parkinson’s disease[3][4][6][8]. Drugs that target these systems often act on their respective reuptake transporters or receptors to modulate synaptic levels. However—since "norepinephrine and dopamine systems" does not refer to a single molecular entity but rather broad interacting networks—it is not considered an individual therapeutic target like a specific receptor or enzyme; thus this entry should be flagged for correction if used where only discrete molecular targets are appropriate. **Note:** This entry describes two interconnected neurotransmitter networks rather than one canonical molecule/receptor/target; it should be replaced with more specific entities such as "Dopamine transporter," "Norepinephrine transporter," "Dopamine D2 receptor," etc., depending on context[3][4][7].
Reuptake inhibition of norepinephrine and dopamine transporters[8]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine and dopamine systems.